TY - CHAP M1 - Book, Section TI - Indolent Lymphomas A1 - Nastoupil, Loretta J. A1 - Cheah, Chan Yoon A1 - Medeiros, L. Jeffrey A1 - Fowler, Nathan H. A2 - Kantarjian, Hagop M. A2 - Wolff, Robert A. Y1 - 2016 N1 - T2 - The MD Anderson Manual of Medical Oncology, 3e AB - The indolent non-Hodgkin lymphomas (NHLs) represent approximately one-third of all malignant lymphomas (1,2); most are of B-cell lineage. Follicular lymphoma (FL) is the most common indolent lymphoma. Other indolent B-cell lymphomas include small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL), the marginal zone B-cell lymphomas (MZLs; extranodal, nodal, and splenic), and lymphoplasmacytic lymphoma (LPL), most cases of which are more specifically classified as Waldenström macroglobulinemia (WM) (Table 7-1) (2). Mantle cell lymphoma can morphologically resemble indolent B-cell lymphomas, but it is often clinically more aggressive and therefore is not covered in this chapter. Indolent T-cell NHLs, such as mycosis fungoides, are also not covered in this chapter. SN - PB - McGraw-Hill Medical CY - New York, NY Y2 - 2024/03/29 UR - hemonc.mhmedical.com/content.aspx?aid=1126740415 ER -